NCT02575079View on ClinicalTrials.gov

Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT

NACompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 29, 2018

Study Completion Date

March 29, 2018

Conditions

Central Line Associated Bloodstream Infections (CLABSI)Bone Marrow Transplant

Interventions

DEVICE

Parafilm

Single-use, pre-cut sections of parafilm over the central venous catheter (CVC) hub (if not connected) or around the CVC hub connection (if connected). Parafilm will be maintained on the CVC until it is removed.

Trial Locations (1)

30322

Children's Healthcare of Atlanta, Atlanta

All Listed Sponsors

lead

Emory University

OTHER

NCT02575079 - Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT | Biotech Hunter | Biotech Hunter